The biggest and most important Psychedelic Medicine Conference in the Southern Hemisphere
International Summit on Psychedelic Therapies
for Mental Illness
2 Day Introductory Workshop program in Psychedelic Therapies
+ 2 Day Public Summit
17 – 20 November 2021
Online Event
Mind Medicine Australia will hold a two-day International Summit on Psychedelic Therapies for Mental Illness online in November 2021, bringing together clinicians, scientists, academics, mental and public health professionals, philanthropists, investors, Government, law and policy leaders, business, industry, consumers and other interested stakeholders.
The event will also feature a two-day pre-Summit introductory workshop program (17-18 November) for anyone with an interest in the topic and who is considering further development of their current therapeutic skills or who are eager to gain a detailed understanding of psychedelic-assisted psychotherapy for the treatment of mental illness.
The Summit will feature a rich program with a mixture of international and national keynotes, workshops, hot spots and panel conversations.
We already have a range of leading international speakers committed for the 2-day summit including:
- Dr Rick Doblin (USA) Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS),
- Professor David Nutt (UK) Head of Neuropsychopharmacology at Imperial College London and lead advisor on psilocybin assisted therapy for treatment-resistant depression,
- Dr Gabor Maté (Canada) renowned trauma and addiction physician,
- Johann Hari (UK) journalist and bestselling author,
- Dr William Richards (USA) Psychologist in the Center for Psychedelic and Consciousness Research,
- Dr Robin Carhart-Harris (UK) Head of the Centre for Psychedelic Research, Imperial College London,
- Francoise Bourzat (USA) Counselor and Author,
- Wade Davis (Canada) Anthropologist, ethnobotanist and Explorer in Residence at the National Geographic Society,
- Dr Alberto Villoldo (USA) Founder the Four Winds Society, Director the Center for Energy Medicine (Chile),
- Dr Ben Sessa (UK) psychiatrist, researcher and writer and currently leading the Imperial College trials on using MDMA therapy for alcohol dependence,
- Dr Gabby Agin-Liebes (USA) Psilocybin researcher at Weill Institute for Neuroscience,
- Matthew Johnson (USA) Associate Professor of Psychiatry at Johns Hopkins University School of Medicine with a focus on psychedelic research for the treatment of mental illness,
- Dr Lynn Marie Morski (USA) President of the Psychedelic Medicine Association,
- Dr Adam Gazzaley (USA) Founder & Executive Director – Neuroscape,
- Patrycja Slawuta (USA) Researcher & Psychologist,
- Dr Adele Lafrance (USA / Canada) Clinical Psychologist and Research Scientist,
- Dr Reid Robinson (USA) Psychedelic Psychiatrist and writer,
- Dr Kate Pate (USA) Neurophysiologist and writer,
- Shlomi Raz (USA) Chairman and CEO of Eleusis,
- Kelsey Ramsden (Canada) Co-Founder, CEO & President of Mindcure,
- Hon Andrew Robb AO (AUS) Former Minister for Trade, Investment and Tourism in Australia,
- John Skerritt (AUS) Deputy Secretary, Health Products Regulation Group,
- Arthur Christopoulos (AUS) Professor of Analytical Pharmacology and Molecular Neuropsychopharmacologist Monash University,
- Dr Simon Longstaff (AUS) Executive Director of The Ethics Centre,
- Admiral Chris Barrie AC (AUS) Former Head of the Australian Defence Force and Strategic Leadership Consultant,
- Dr Eli Kotler (AUS) Psychiatrist and Director of Medicine at Malvern Private Hospital,
- Vince Polito (AUS) Senior Research Fellow in the Department of Cognitive Science at Macquarie University in Sydney,
- Tania de Jong AM (AUS) Founder Creative Universe, Creativity Australia, Creative Innovation Global and Mind Medicine Australia,
- Peter Hunt AM (AUS) Investment Banker & engaged Philanthropist; Founder Women’s Community Shelters and Mind Medicine Australia,
and more to be announced.